KARA IZZO: Open Payments
NPI 1093407066 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 82 payments from 28 companies in 2025. Trend: 2023 $166 · 2024 $1,084 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 13 | $280 |
| UCB, Inc. | 7 | $199 |
| ABBVIE INC. | 8 | $167 |
| TG Therapeutics, Inc. | 4 | $126 |
| Biogen, Inc. | 5 | $118 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Alexion Pharmaceuticals, Inc. | 4 | $79 |
| Genentech USA, Inc. | 3 | $66 |
| Lundbeck LLC | 2 | $62 |
Products named: BRIUMVI, TYSABRI, BOTOX, PONVORY, Rystiggo, HYQVIA, ULTOMIRIS, VYEPTI.
Industry payments across CT — which companies pay providers there.
